Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01853046 |
| Title | Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Bayer |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Los Angeles | California | 90033 | United States | Details | ||
| Aurora | Colorado | 80045 | United States | Details | ||
| St. Louis | Missouri | 63110 | United States | Details | ||
| Lebanon | New Hampshire | 03756 | United States | Details | ||
| Buffalo | New York | 14263-0001 | United States | Details | ||
| Edmonton | Alberta | T6G 1Z2 | Canada | Details | ||
| Vancouver | British Columbia | V5Z 4E6 | Canada | Details | ||
| Hamilton | Ontario | L8V 5C2 | Canada | Details | ||
| Montreal | Quebec | H2L 4M1 | Canada | Details |